Myocarditis Clinical Trial
Official title:
Value of Heart Rate Lowering Therapy in Acute Myocarditis
NCT number | NCT06312891 |
Other study ID # | VOHRLTIAM |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 1, 2024 |
Est. completion date | June 1, 2025 |
To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | June 1, 2025 |
Est. primary completion date | April 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Adults: =18 years of age. - Presentation: at least one of the following: - Myopericarditis/ACS-like - MINOCA - Arrhythmias: brady or tachyarrhythmias. - Unexplained compensated acute cardiomyopathy (excluded ischemic, valvular, hypertensive, metabolic, and toxic causes of cardiomyopathy as indicated clinically). - TTE: LVEF>40% - CMR-confirmed myo(peri)carditis (Lake Louise criteria) Exclusion Criteria: - • Rheumatic carditis. - Connective tissue diseases (-ve ANA). - Cancer chemotherapy. - Toxicity from immunotherapy. - Vaccine-related myocarditis. - Presence of coronary artery disease. - Peripartum (occurring during the last month of pregnancy or within 5 months after delivery) - ECG: atrial fibrillation/flutter. - Resuscitated sudden death. - Early/initial phase of decompensated heart failure. - Tamponade complicating pericarditis unless successfully managed. |
Country | Name | City | State |
---|---|---|---|
Egypt | Heart Hospital | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Value of Heart Rate Lowering Therapy in Acute Myocarditis | To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction. | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05911386 -
Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
|
||
Not yet recruiting |
NCT04085718 -
FDG-PET/CT Images Comparing to MRI and Endomyocardial Biopsy in Myocarditis
|
||
Enrolling by invitation |
NCT05610423 -
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
|
||
Active, not recruiting |
NCT05195645 -
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
|
Phase 2 | |
Recruiting |
NCT05184114 -
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance
|
N/A | |
Recruiting |
NCT04612296 -
The Heart Hive - Cardiomyopathy Study
|
||
Recruiting |
NCT04673409 -
CMR Imaging of Autoimmune Diseases
|
||
Recruiting |
NCT05295290 -
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
|
Phase 4 | |
Completed |
NCT03777839 -
PET-FDG in Myocarditis
|
||
Completed |
NCT06447935 -
Acute Eosinophilic Myocarditis International Registry
|
||
Not yet recruiting |
NCT05125965 -
Contribution of Cardiac MRI in the Early Diagnosis of Myocarditis Induced by Immunotherapy
|
N/A | |
Active, not recruiting |
NCT04444128 -
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
|
||
Recruiting |
NCT06158698 -
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
|
Phase 3 | |
Recruiting |
NCT05282498 -
Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)
|
||
Recruiting |
NCT05288426 -
Myocarditis Post Vaccination or Multi System Inflammatory Syndrome
|
||
Recruiting |
NCT03801681 -
ARrhythmias in MYocarditis
|
||
Recruiting |
NCT06116084 -
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
|
N/A | |
Completed |
NCT04413071 -
Cardiac COVID-19 Health Care Workers
|
||
Recruiting |
NCT05414162 -
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
|
||
Recruiting |
NCT06409585 -
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
|